| Meghann Mulherin, | |
|
200 Hospital Dr Ste 300, Glen Burnie, MD 21061-5884 | |
| (410) 837-2050 | |
| (866) 629-0091 |
| Full Name | Meghann Mulherin |
|---|---|
| Gender | Female |
| Speciality | Clinical Social Worker |
| Experience | 14 Years |
| Location | 200 Hospital Dr Ste 300, Glen Burnie, Maryland |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164808218 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 17606 (Maryland) | Primary |
| Entity Name | Chase Brexton Health Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588606305 PECOS PAC ID: 5395644835 Enrollment ID: O20040512000520 |
News Archive
Aiming for lower than standard blood pressure targets offers no known clinical benefit, according to a Cochrane Review. In a systematic review of the evidence, researchers found that using antihypertensive drugs to reduce blood pressure below the 140/90 mm Hg standard was not associated with any reduction in death rates or serious morbidity.
Alternative health remedies are increasingly important in the health care marketplace. A new study in the Journal of Consumer Research explores how consumers choose among the many available remedies.
PhotoMedex, Inc. today announced that it has closed a private placement of approximately 4.17 million shares of its common stock at a price of $0.65 per share. Gross proceeds from the private placement are approximately $2.7 million. The purchasers were accredited investors, some of which were institutions.
The reported results of a one-year phase III study in 1045 people with type 2 diabetes treated with rimonabant, the first in a new class of therapeutic agents called selective CB1 Blockers, were that rimonabant 20 mg significantly improved HbA1c (a measure of blood sugar control), dyslipidemia (abnormal levels of fat in the blood), and systolic blood pressure with a concomitant substantial reduction in abdominal obesity in people with type 2 diabetes treated with oral anti-diabetic medications and requiring further control.
Health and Human Services Secretary Kathleen Sebelius and Centers for Medicare and Medicaid Services Administrator Donald Berwick announced the release of the proposed rule Thursday, offering insights into how the administration hopes to encourage doctors and hospitals to collaborate more closely to improve patient care.
› Verified 5 days ago
| Entity Name | Della Behavioral Health Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750635207 PECOS PAC ID: 3971755000 Enrollment ID: O20121218000204 |
News Archive
Aiming for lower than standard blood pressure targets offers no known clinical benefit, according to a Cochrane Review. In a systematic review of the evidence, researchers found that using antihypertensive drugs to reduce blood pressure below the 140/90 mm Hg standard was not associated with any reduction in death rates or serious morbidity.
Alternative health remedies are increasingly important in the health care marketplace. A new study in the Journal of Consumer Research explores how consumers choose among the many available remedies.
PhotoMedex, Inc. today announced that it has closed a private placement of approximately 4.17 million shares of its common stock at a price of $0.65 per share. Gross proceeds from the private placement are approximately $2.7 million. The purchasers were accredited investors, some of which were institutions.
The reported results of a one-year phase III study in 1045 people with type 2 diabetes treated with rimonabant, the first in a new class of therapeutic agents called selective CB1 Blockers, were that rimonabant 20 mg significantly improved HbA1c (a measure of blood sugar control), dyslipidemia (abnormal levels of fat in the blood), and systolic blood pressure with a concomitant substantial reduction in abdominal obesity in people with type 2 diabetes treated with oral anti-diabetic medications and requiring further control.
Health and Human Services Secretary Kathleen Sebelius and Centers for Medicare and Medicaid Services Administrator Donald Berwick announced the release of the proposed rule Thursday, offering insights into how the administration hopes to encourage doctors and hospitals to collaborate more closely to improve patient care.
› Verified 5 days ago
| Entity Name | Mindful Journey Counseling Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861113268 PECOS PAC ID: 4385010032 Enrollment ID: O20221020001388 |
News Archive
Aiming for lower than standard blood pressure targets offers no known clinical benefit, according to a Cochrane Review. In a systematic review of the evidence, researchers found that using antihypertensive drugs to reduce blood pressure below the 140/90 mm Hg standard was not associated with any reduction in death rates or serious morbidity.
Alternative health remedies are increasingly important in the health care marketplace. A new study in the Journal of Consumer Research explores how consumers choose among the many available remedies.
PhotoMedex, Inc. today announced that it has closed a private placement of approximately 4.17 million shares of its common stock at a price of $0.65 per share. Gross proceeds from the private placement are approximately $2.7 million. The purchasers were accredited investors, some of which were institutions.
The reported results of a one-year phase III study in 1045 people with type 2 diabetes treated with rimonabant, the first in a new class of therapeutic agents called selective CB1 Blockers, were that rimonabant 20 mg significantly improved HbA1c (a measure of blood sugar control), dyslipidemia (abnormal levels of fat in the blood), and systolic blood pressure with a concomitant substantial reduction in abdominal obesity in people with type 2 diabetes treated with oral anti-diabetic medications and requiring further control.
Health and Human Services Secretary Kathleen Sebelius and Centers for Medicare and Medicaid Services Administrator Donald Berwick announced the release of the proposed rule Thursday, offering insights into how the administration hopes to encourage doctors and hospitals to collaborate more closely to improve patient care.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Meghann Mulherin, 1111 N Charles St, Baltimore, MD 21201-5505 Ph: (410) 837-2050 | Meghann Mulherin, 200 Hospital Dr Ste 300, Glen Burnie, MD 21061-5884 Ph: (410) 837-2050 |
News Archive
Aiming for lower than standard blood pressure targets offers no known clinical benefit, according to a Cochrane Review. In a systematic review of the evidence, researchers found that using antihypertensive drugs to reduce blood pressure below the 140/90 mm Hg standard was not associated with any reduction in death rates or serious morbidity.
Alternative health remedies are increasingly important in the health care marketplace. A new study in the Journal of Consumer Research explores how consumers choose among the many available remedies.
PhotoMedex, Inc. today announced that it has closed a private placement of approximately 4.17 million shares of its common stock at a price of $0.65 per share. Gross proceeds from the private placement are approximately $2.7 million. The purchasers were accredited investors, some of which were institutions.
The reported results of a one-year phase III study in 1045 people with type 2 diabetes treated with rimonabant, the first in a new class of therapeutic agents called selective CB1 Blockers, were that rimonabant 20 mg significantly improved HbA1c (a measure of blood sugar control), dyslipidemia (abnormal levels of fat in the blood), and systolic blood pressure with a concomitant substantial reduction in abdominal obesity in people with type 2 diabetes treated with oral anti-diabetic medications and requiring further control.
Health and Human Services Secretary Kathleen Sebelius and Centers for Medicare and Medicaid Services Administrator Donald Berwick announced the release of the proposed rule Thursday, offering insights into how the administration hopes to encourage doctors and hospitals to collaborate more closely to improve patient care.
› Verified 5 days ago
Deadra Carnack Atkins, LCSW-C Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 122 Langley Rd N, Suite A, Glen Burnie, MD 21060 Phone: 410-222-6785 | |
David A Nunez, LMSW, CAC-AD Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 102 6th Ave Ne Ste B, Glen Burnie, MD 21060 Phone: 410-320-9967 Fax: 443-835-3925 | |
Ashley Nicole Palestis, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 122 Langley Rd N Ste A, Glen Burnie, MD 21060 Phone: 410-222-6785 | |
Janet Silber, LCSW-C Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 30 Greenway St Nw Ste 5, Glen Burnie, MD 21061 Phone: 410-760-9079 | |
Vicki Fearey, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 7310 Ritchie Highway, Suite 1009, Glen Burnie, MD 21061 Phone: 410-768-5988 | |
Kelly Hoenshell, Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 217 Allen Rd, Glen Burnie, MD 21061 Phone: 443-557-8730 | |
Kristilee P Sheffler, LGSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 804 Landmark Dr, Suite 118, Glen Burnie, MD 21061 Phone: 410-863-7213 Fax: 410-863-7205 |